Stomatologie

, Volume 107, Issue 4, pp 55–60 | Cite as

Osteoporose – Risikofaktor in der Zahnheilkunde?

Fortbildung

Zusammenfassung

Osteoporose bezeichnet einen Komplex von Erkrankungen, die durch eine verringerte Knochenmasse und Knochenqualität gekennzeichnet ist. Osteoporose betrifft etwa ein Viertel der weiblichen Bevölkerung ab dem 65. Lebensjahr. Auch einer von fünf Männern wird eine osteoporotische Fraktur im Laufe des Lebens erleiden. Für den Zahnarzt stellen sich drei wesentliche Fragen, nämlich (Frage 1) sind Patienten mit Osteoporose potentielle Risikopatienten in der Zahnheilkunde, (Frage 2) welche Auswirkungen hat die pharmakologische Osteoporosetherapie in der Zahnheilkunde, und (Frage 3) kann der Zahnarzt durch Vermessung des Alveolarknochens das Risiko einer Osteoporose abschätzen? Die Beantwortung der beiden ersten Fragen würde dem Zahnarzt eine individualisierte Therapie osteoporotischer Patienten ermöglichen. Die Beantwortung der dritten Frage würde dem Zahnarzt die Früherkennung von Patienten mit einem Risiko für Osteoporose erlauben. Die Annahme eines Zusammenhangs zwischen Osteoporose und Aspekten der Zahnmedizin ist wissenschaftliche Grundlage klinischer und präklinischer Studien. Es sind aber genau jene Studien die zu einer differenzierten Sichtweise dieser Thematik ermahnen und in der vorliegenden Übersichtsarbeit zusammenfassend dargestellt werden.

Schlüsselwörter

Osteoporose Zahnverlust Parodontologie Implantologie Radiologie Risikopatient Alveolarknochen Osseointegration Evidenz-basierte Medizin 

Osteoporosis – risk factor in dentistry?

Summary

Osteoporosis refers to a complex of diseases, marked by a reduced bone mass and bone quality. Osteoporosis affects about one quarter of the female population from the 65th year of life. Also one in five men will suffer an osteoporotic fracture during their lifetime. Dentists have to ask three key questions, namely (question 1) are patents with osteoporosis potential risk patients in dentistry, (question 2) what is the impact of pharmacological osteoporosis therapy in dentistry, and (question 3), can a dentist by measuring the alveolar bone of osteoporosis risk estimate of his patients? To answer the first two questions would allow the dentist to individualize treatment options of osteoporotic patients. Answering the third question, would allow the dentist to screen for patients at risk for osteoporosis. The assumption of a link between aspects of dentistry and osteoporosis seems justified and is the scientific basis of clinical and preclinical studies. However, exactly those studies add to a differentiated view of this topic which are presented and summarized in this review.

Keywords

Osteoporosis Tooth loss Periodontal disease Implant dentistry Radiology Risk patient Alveolar bone Osseointegration Evidence-based medicine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Agis H, Blei J, Watzek G, Gruber R (2010) Is zoledronate toxic to human periodontal fibroblasts? J Dent Res 89: 40–45CrossRefPubMedGoogle Scholar
  2. Alsaadi G, Quirynen M, Komarek A, van Steenberghe D (2007) Impact of local and systemic factors on the incidence of oral implant failures, up to abutment connection. J Clin Periodontol 34: 610–617CrossRefPubMedGoogle Scholar
  3. Alsaadi G, Quirynen M, Komarek A, van Steenberghe D (2008) Impact of local and systemic factors on the incidence of late oral implant loss. Clin Oral Implan Res 19: 670–676CrossRefGoogle Scholar
  4. Alsaadi G, Quirynen M, Michiles K, Teughels W, Komarek A, van Steenberghe D (2008) Impact of local and systemic factors on the incidence of failures up to abutment connection with modified surface oral implants. J Clin Periodontol 35: 51–57PubMedGoogle Scholar
  5. Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, et al. (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356: 1809–1822CrossRefPubMedGoogle Scholar
  6. Blomqvist JE, Alberius P, Isaksson S, Linde A, Hansson BG (1996) Factors in implant integration failure after bone grafting: an osteometric and endocrinologic matched analysis. Int J Oral Maxillofac Surg 25: 63–68CrossRefPubMedGoogle Scholar
  7. Bollen AM, Taguchi A, Hujoel PP, Hollender LG (2004) Number of teeth and residual alveolar ridge height in subjects with a history of self-reported osteoporotic fractures. Osteoporos Int 15: 970–974CrossRefPubMedGoogle Scholar
  8. Bornstein MM, Cionca N, Mombelli A (2009) Systemic conditions and treatments as risks for implant therapy. Int J Oral Maxillofac Implants 24 Suppl: 12–27PubMedGoogle Scholar
  9. Brennan-Calanan RM, Genco RJ, Wilding GE, Hovey KM, Trevisan M, Wactawski-Wende J (2008) Osteoporosis and oral infection: independent risk factors for oral bone loss. J Dent Res 87: 323–327CrossRefPubMedGoogle Scholar
  10. Brennan RM, Genco RJ, Hovey KM, Trevisan M, Wactawski-Wende J (2007) Clinical attachment loss, systemic bone density, and subgingival calculus in postmenopausal women. J Periodontol 78: 2104–2111CrossRefPubMedGoogle Scholar
  11. Carvas JS, Pereira RM, Caparbo VF, Fuller P, Silveira CA, Lima LA, et al. (2009) A single dose of zoledronic acid reverses the deleterious effects of glucocorticoids on titanium implant osseointegration. Osteoporos IntGoogle Scholar
  12. Famili P, Cauley J, Suzuki JB, Weyant R (2005) Longitudinal study of periodontal disease and edentulism with rates of bone loss in older women. J Periodontol 76: 11–15CrossRefPubMedGoogle Scholar
  13. Geraets WG, Verheij JG, van der Stelt PF, Horner K, Lindh C, Nicopoulou-Karayianni K, et al. (2008) Selecting regions of interest on intraoral radiographs for the prediction of bone mineral density. Dentomaxillofac Radiol 37: 375–379CrossRefPubMedGoogle Scholar
  14. Grant BT, Amenedo C, Freeman K, Kraut RA (2008) Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases. J Oral Maxillofac Surg 66: 223–230CrossRefPubMedGoogle Scholar
  15. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357: 266–281CrossRefPubMedGoogle Scholar
  16. Javed F, Almas K (2010) Osseointegration of dental implants in patients undergoing bisphosphonate treatment: a literature review. J Periodontol 81: 479–484CrossRefPubMedGoogle Scholar
  17. Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F, et al. (2008) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 19: 399–428CrossRefPubMedGoogle Scholar
  18. Kanis JA, McCloskey EV, Johansson H, Oden A (2009) Approaches to the targeting of treatment for osteoporosis. Nat Rev Rheumatol 5: 425–431CrossRefPubMedGoogle Scholar
  19. Karayianni K, Horner K, Mitsea A, Berkas L, Mastoris M, Jacobs R, et al. (2007) Accuracy in osteoporosis diagnosis of a combination of mandibular cortical width measurement on dental panoramic radiographs and a clinical risk index (OSIRIS): the OSTEODENT project. Bone 40: 223–229CrossRefPubMedGoogle Scholar
  20. Kingsmill VJ, Gray CM, Moles DR, Boyde A (2007) Cortical vascular canals in human mandible and other bones. J Dent Res 86: 368–372CrossRefPubMedGoogle Scholar
  21. Krall EA (2006) Osteoporosis and the risk of tooth loss. Clin Calcium 16: 287–290PubMedGoogle Scholar
  22. Krall EA, Wehler C, Garcia RI, Harris SS, Dawson-Hughes B (2001) Calcium and vitamin D supplements reduce tooth loss in the elderly. Am J Med 111: 452–456CrossRefPubMedGoogle Scholar
  23. Krauth MT, Fugl A, Gruber R (2008) [Bisphosphonate-associated osteonecrosis of the jaw]. Wien Klin Wochenschr 120: 467–476CrossRefPubMedGoogle Scholar
  24. Kudlacek S, Schneider B, Peterlik M, Leb G, Klaushofer K, Weber K, et al. (2003) Assessment of vitamin D and calcium status in healthy adult Austrians. Eur J Clin Invest 33: 323–331CrossRefPubMedGoogle Scholar
  25. Laine MA, Sewon LA, Karjalainen SM, Helenius H, Doroguinskaia A, Lehtonen-Veromaa M (2002) Salivary variables in relation to tobacco smoking and female sex steroid hormone-use in 30 to 59-year-old women. Acta Odontol Scand 60: 237–240CrossRefPubMedGoogle Scholar
  26. Lekholm U, Zarb GA (1985) Patient selection and preparation. In: Brånemark P-I, Zarb G & Albrektsson T (eds). Tissue Integrated Prosthesis: Osseointegration in Clinical Dentistry, pp. 199. Chicago: Quintessence Publishing Co IncGoogle Scholar
  27. Lo JC, O'Ryan FS, Gordon NP, Yang J, Hui RL, Martin D, et al. (2010) Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg 68: 243–253CrossRefPubMedGoogle Scholar
  28. Madrid C, Sanz M (2009) What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review. Clin Oral Implants Res 20 Suppl 4: 87–95CrossRefPubMedGoogle Scholar
  29. Mair B, Tangl S, Feierfeil J, Skiba D, Watzek G, Gruber R (2009) Age-related efficacy of parathyroid hormone on osseointegration in the rat. Clin Oral Implants Res 20: 400–405CrossRefPubMedGoogle Scholar
  30. Mavropoulos A, Rizzoli R, Ammann P (2007) Different responsiveness of alveolar and tibial bone to bone loss stimuli. J Bone Miner Res 22: 403–410CrossRefPubMedGoogle Scholar
  31. Miley DD, Garcia MN, Hildebolt CF, Shannon WD, Couture RA, Anderson Spearie CL, et al. (2009) Cross-sectional study of vitamin D and calcium supplementation effects on chronic periodontitis. J Periodontol 80: 1433–1439CrossRefPubMedGoogle Scholar
  32. Nicopoulou-Karayianni K, Tzoutzoukos P, Mitsea A, Karayiannis A, Tsiklakis K, Jacobs R, et al. (2009) Tooth loss and osteoporosis: the OSTEODENT Study. J Clin Periodontol 36: 190–197CrossRefPubMedGoogle Scholar
  33. Phipps KR, Chan BK, Madden TE, Geurs NC, Reddy MS, Lewis CE, et al. (2007) Longitudinal study of bone density and periodontal disease in men. J Dent Res 86: 1110–1114CrossRefPubMedGoogle Scholar
  34. Riggs BL, Parfitt AM (2005) Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling. J Bone Miner Res 20: 177–184CrossRefPubMedGoogle Scholar
  35. Rocha ML, Malacara JM, Sanchez-Marin FJ, Vazquez de la Torre CJ, Fajardo ME (2004) Effect of alendronate on periodontal disease in postmenopausal women: a randomized placebo-controlled trial. J Periodontol 75: 1579–1585CrossRefPubMedGoogle Scholar
  36. Taguchi A, Fujiwara S, Masunari N, Suzuki G (2004) Self-reported number of remaining teeth is associated with bone mineral density of the femoral neck, but not of the spine, in Japanese men and women. Osteoporos Int 15: 842–846CrossRefPubMedGoogle Scholar
  37. Tsolaki IN, Madianos PN, Vrotsos JA (2009) Outcomes of dental implants in osteoporotic patients. A literature review. J Prosthodont 18: 309–323CrossRefPubMedGoogle Scholar
  38. Ulm C, Kneissel M, Schedle A, Solar P, Matejka M, Schneider B, et al. (1999) Characteristic features of trabecular bone in edentulous maxillae. Clin Oral Implants Res 10: 459–467CrossRefPubMedGoogle Scholar
  39. Ulm CW, Kneissel M, Hahn M, Solar P, Matejka M, Donath K (1997) Characteristics of the cancellous bone of edentulous mandibles. Clin Oral Implants Res 8: 125–130CrossRefPubMedGoogle Scholar
  40. Verheij JG, Geraets WG, van der Stelt PF, Horner K, Lindh C, Nicopoulou-Karayianni K, et al. (2009) Prediction of osteoporosis with dental radiographs and age. Dentomaxillofac Radiol 38: 431–437CrossRefPubMedGoogle Scholar
  41. Wactawski-Wende J, Hausmann E, Hovey K, Trevisan M, Grossi S, Genco RJ (2005) The association between osteoporosis and alveolar crestal height in postmenopausal women. J Periodontol 76: 2116–2124CrossRefPubMedGoogle Scholar
  42. Woo SB, Hellstein JW, Kalmar JR (2006) Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144: 753–761PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.Universitätsklinik für Zahn-, Mund- und Kieferheilkunde, Abt. Orale ChirurgieMedizinische Universität WienWienAustria

Personalised recommendations